0ME:FRA
Twist Bioscience Corp
€116.85
arrow_downward
-2.18%(-2.60) 1D
Aug 25, 9:55:02 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0ME...
Open
€117.10
High
€117.10
Low
€116.85
Mkt. cap
9.33B
Avg. vol.
30.00
Volume
0.00
52-wk high
€120.50
52-wk low
€20.36
Shares outstanding
222.04M
No. of employees
979
Open
€117.10
High
€117.10
Low
€116.85
Mkt. cap
9.33B
Avg. vol.
30.00
Volume
0.00
52-wk high
€120.50
52-wk low
€20.36
Shares outstanding
222.04M
No. of employees
979
News stories
From web sources and news partners
GuruFocus
·
11 hours ago
Twist Bioscience Corp (TWST) Shares Fall 3.3% -- What GF Score o
Stock Titan
·
14 hours ago
Twist Bioscience (NASDAQ: TWST) officer sets 854-share sale tied to equity taxes
Investing.com
·
22 hours ago
Guggenheim reiterates Twist Bioscience stock rating on AI drug discovery potential
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp
AI content may include mistakes. Learn more